Modulation of blood pressure by estrogen: A modeling analysis

Area of Science:

• Cardiovascular Physiology
• Endocrinology
• Computational Biology

Background:

• Hypertension affects one billion people globally, posing a significant cardiovascular disease risk.
• Premenopausal women exhibit lower blood pressure and hypertension rates than men, a protective effect lost after menopause due to declining estrogen.
• The exact mechanisms of estrogen's cardiovascular protection remain unclear, despite its known interactions with various physiological systems regulating blood pressure.

Purpose of the Study:

• To identify the key factors contributing to estrogen-mediated cardiovascular protection.
• To elucidate the role of estrogen in blood pressure regulation and hypertension development.

Main Methods:

• Development of a computational model simulating blood pressure regulation.
• Incorporation of estrogen's effects on the renin-angiotensin system, sympathetic nervous activity, vascular tone, and renal transport.
• Analysis of model simulations to determine primary contributors to estrogen's protective effects.

Main Results:

• Estrogen's vasodilatory action, particularly on afferent arterioles, is identified as the main contributor to lower blood pressure and hypertension resistance in premenopausal women.
• Model simulations indicate that angiotensin receptor blockers may be more effective than angiotensin converting enzyme inhibitors for treating hypertension in women across their lifespan, even with decreasing estrogen levels.

Conclusions:

• Estrogen's vasodilatory effects are crucial for cardiovascular protection in premenopausal women.
• The findings suggest potential sex-specific differences in hypertension treatment strategies, favoring angiotensin receptor blockers for women.